Sign in
4

Changes in Ownership

Royalty Pharma plc Filed Acc 0001802768-23-000030

Director acquired 475,590 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
RIGGS RORY B Director 2023-11-13 Conversion +475,590 490,099 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
RIGGS RORY B Director 2023-11-13 Conversion · LP interests in RPI US Partners 2019, LP −47,559 300,000 D: show line 2 in the form
Loading xslF345X05/wk-form4_1700000224.xml…